China Pharma Holdings, Inc.CPHINYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank53
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P53
Within normal range
vs 5Y Ago
-15.2x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$-1.63M+17.2%
2024$-1.96M-23383.1%
2023$8436.00+101.0%
2022$-837689.00-463.7%
2021$230345.00+115.6%
2020$106852.00+100.6%
2019$-17.45M-144.1%
2018$-7.15M+53.3%
2017$-15.32M-209.8%
2016$-4.95M-